Metformin
Metformin Hydrochloride (Off-Label Longevity)
A first-line diabetes drug with 60+ years of clinical history, now emerging as the most evidence-backed pharmaceutical for anti-aging. The Bannister study showed metformin users outliving non-diabetic controls, and the TAME trial is the first FDA-approved trial targeting aging itself.
How Metformin Works
Metformin primarily acts by activating AMP-activated protein kinase (AMPK) through inhibition of mitochondrial respiratory chain complex I, reducing hepatic glucose production and improving peripheral insulin sensitivity. For longevity, its mechanisms include: (1) AMPK activation, which inhibits mTOR and activates autophagy; (2) reduction of insulin and IGF-1 signaling — pathways linked to accelerated aging; (3) anti-inflammatory effects through reduction of NF-kB signaling and inflammatory cytokines; (4) potential beneficial effects on the gut microbiome. The TAME trial (Targeting Aging with Metformin) is the landmark study investigating metformin specifically for aging in non-diabetic individuals.
📊 Evidence by Outcome
36% reduction in all-cause mortality (UKPDS 34); metformin users outlive non-diabetic controls by 15% (Bannister 2014). 53-study meta-analysis confirms geroprotective effects.
53 studies • Consistency: High • Effect: Large
42% reduction in diabetes-related death (UKPDS 34). HR=0.76 for CVD vs non-metformin therapies.
30 studies • Consistency: High • Effect: Large
31% reduction in cancer incidence and 34% in cancer mortality in pooled analysis of 47 studies. Effect attenuated to 10-18% after bias correction.
47 studies • Consistency: Moderate • Effect: Moderate
31% reduction in diabetes incidence in pre-diabetic populations (DPP, NEJM 2002). NNT=13.9 over 3 years.
10 studies • Consistency: High • Effect: Large
Key Research
Peer-Reviewed Evidence • 4 Citations
Can people with type 2 diabetes live longer than those without?
Bannister CA et al.•Diabetes Obes Metab•2014•PMID: 25041462
Key Finding: Metformin users lived 15% longer than matched non-diabetic controls (n=180,926, 503,384 person-years).
View on PubMedEffect of intensive blood-glucose control with metformin (UKPDS 34)
UKPDS Group•The Lancet•1998•PMID: 9742977
Key Finding: Landmark RCT: metformin reduced all-cause mortality by 36%, diabetes-related death by 42% over 10.7 years.
View on PubMedMetformin reduces all-cause mortality and diseases of ageing: systematic review
Campbell JM et al.•Ageing Res Rev•2017•PMID: 28802803
Key Finding: 53-study meta-analysis: metformin users had lower all-cause mortality than non-diabetics (HR=0.93).
View on PubMedMetformin as a Tool to Target Aging
Barzilai N et al.•Cell Metab•2016•PMID: 27304507
Key Finding: Outlines the TAME trial — first FDA-approved clinical trial testing a drug for aging as an indication.
View on PubMedCitations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.
Side Effects & Safety
Interactions & Contraindications
Drug Interactions
- •Iodinated contrast dye (CT scans, angiograms) — must discontinue metformin 48 hours before and after to prevent lactic acidosis; kidney function must be confirmed before restarting
- •Alcohol — increases lactic acidosis risk substantially; heavy drinking is a contraindication
- •Carbonic anhydrase inhibitors (topiramate, acetazolamide) — increase lactic acidosis risk
- •Cimetidine — reduces renal clearance of metformin, increasing levels
- •ACE inhibitors and diuretics — may impair kidney function, affecting metformin clearance
- •Other diabetes medications (insulin, sulfonylureas) — additive hypoglycemia risk (though metformin alone rarely causes hypoglycemia)
Supplement Interactions
- •Berberine — similar mechanism of action (AMPK activation); combined effect may increase GI side effects and hypoglycemia risk
- •Vitamin B12 supplementation — recommended with long-term metformin use to prevent deficiency
- •Alpha-lipoic acid — may enhance glucose-lowering effects
Food & Timing
- •Take with meals to reduce GI side effects (this is standard medical advice)
- •High-fiber diets may worsen initial GI symptoms
- •Alcohol must be limited — increases lactic acidosis risk and can cause hypoglycemia
- •Extended-release formulation (metformin XR) is better tolerated with food
Who Should Avoid
- •Moderate to severe kidney impairment (eGFR < 30 mL/min — contraindicated; eGFR 30-45 — use with caution and dose reduction)
- •Acute or chronic metabolic acidosis including diabetic ketoacidosis
- •Severe liver disease — impaired lactate clearance increases lactic acidosis risk
- •Heart failure requiring pharmacological treatment — increased lactic acidosis risk (though recent data suggests metformin may actually be beneficial in stable heart failure)
- •Acute conditions that may impair kidney function: dehydration, severe infection, shock
- •Within 48 hours of iodinated contrast administration
- •Active alcohol use disorder
- •Pregnancy — not approved for gestational diabetes in most guidelines (though used off-label in some contexts)
📋 Protocol Snapshot
Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.
Cost Guide
AED 30-150/month
Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.
Frequently Asked Questions
No. Metformin is approved only for type 2 diabetes. The TAME (Targeting Aging with Metformin) trial is the first major clinical trial investigating metformin specifically for aging in non-diabetic adults. Until results are available, all longevity use is off-label based on observational data showing diabetic patients on metformin have lower all-cause mortality than non-diabetic controls.
Metformin is widely available and affordable in UAE pharmacies with a prescription. Some longevity physicians in Dubai prescribe it off-label for aging prevention after assessing metabolic health. It is one of the safest and most well-studied medications in history, with over 60 years of clinical use. However, medical supervision is still essential.
Diabetes doses typically range from 1,000-2,550mg daily. Longevity protocols generally use 500-1,500mg daily, often starting at 500mg extended-release (XR) and titrating up over 2-4 weeks to minimize GI side effects. There is no established optimal longevity dose — this is an area of active research.
Yes, this is a real and common concern. Metformin impairs B12 absorption in the ileum. Monitor B12 levels annually (or more frequently in the first year) and supplement if levels decline. Symptoms of B12 deficiency include fatigue, numbness/tingling, and cognitive changes. Many UAE longevity clinics include B12 monitoring in their metformin protocols.
Some research suggests metformin may blunt certain exercise adaptations, particularly mitochondrial biogenesis and muscle hypertrophy in older adults. This is a genuine concern in the longevity community. Some practitioners recommend cycling metformin (e.g., taking it on rest days, skipping on heavy exercise days), though this strategy is not yet evidence-based. The interaction between metformin and exercise is an active area of research.
Where to Get It (UAE)
Related Treatments
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, safety, accessibility, and value — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.